Disproquima S.A.:企業の戦略・SWOT・財務情報

◆英語タイトル:Disproquima S.A. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C1589
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スペイン
◆産業分野:材料
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Disproquima S.A. – Strategy, SWOT and Corporate Finance Report
Summary

Disproquima S.A. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Disproquima S.A. (Disproquima) is a marketer and distributor of a range of functional ingredients. The company’s product portfolio includes active pharmaceutical ingredients, vitamins and minerals, antioxidants, compression agents, disgregation agents, solution stabilizers, sweeteners and cellulose derivatives. It primarily caters to the pharmaceutical, food, personal care and feed industries. Disproquima performs operations across Spain, Madrid, Portugal, Brazil, France, Germany, Italy, Mexico, India, Morocco, Algeria, Tunisia and China. The company operates in accordance with the ISO 9001 and ISO 22000 quality standards, and meets the legal requirements of GMP, GDP, REACH, and CLP for its products. Disproquima is headquartered in Barcelona, Spain.

Scope

- Detailed information on Disproquima S.A. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Disproquima S.A. in the form of a SWOT analysis
- An in-depth view of the business model of Disproquima S.A. including a breakdown and examination of key business segments
- Intelligence on Disproquima S.A. ‘s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Disproquima S.A. , such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Disproquima S.A. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Disproquima S.A. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Disproquima S.A. ‘s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 4
Disproquima S.A. : Company Overview 6
Disproquima S.A. : Overview and Key Facts 6
Disproquima S.A. : Overview 6
Disproquima S.A. : Key Facts 6
Disproquima S.A. : Major Products and Services 7
Disproquima S.A. : Company History 8
Disproquima S.A. : Locations and Subsidiaries 9
Disproquima S.A. : Key Competitors 10
Disproquima S.A. : Company Analysis 11
Disproquima S.A. : Business Description 11
Disproquima S.A. : SWOT Analysis 12
Disproquima S.A. : SWOT Overview 12
Disproquima S.A. : Strengths 12
Disproquima S.A. : Weaknesses 13
Disproquima S.A. : Opportunities 13
Disproquima S.A. : Threats 14
Appendix 15
Contact Us 15
Methodology 15
About MarketLine 16

List of Tables
Table 1: Disproquima S.A. : Key Facts
Table 2: Disproquima S.A. : Locations and Subsidiaries
Table 3: Disproquima S.A. : Key Competitors



★海外企業調査レポート[Disproquima S.A.:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Westminster Group plc:企業の戦略・SWOT・財務分析
    Westminster Group plc - Strategy, SWOT and Corporate Finance Report Summary Westminster Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Roust Corporation:企業のM&A・事業提携・投資動向
    Roust Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Roust Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Gentera SAB de CV (GENTERA):企業の財務・戦略的SWOT分析
    Gentera SAB de CV (GENTERA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • St. Mary’s Hospital-製薬・医療分野:企業M&A・提携分析
    Summary St. Mary's Hospital (St. Mary's), a subsidiary of MedStar Health is a healthcare service provider that offers inpatient and outpatient treatment and diagnostic services. The hospital’s services include cardiac, emergency services, family birth, geriatric, neuroscience, oncology, orthopedics, …
  • NTUC Income Insurance Co-operative Limited:企業の戦略的SWOT分析
    NTUC Income Insurance Co-operative Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors an …
  • Kineta Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Kineta Inc (Kineta) is a biotech company that develops novel immuno-therapies. The company offers small-molecule compounds that target RIG-I-like receptor pathways and intracellular IRF3-inducing pathways for applications in cancer. Its KCP-400 is a novel non-opioid therapy for the treatment …
  • MBNA Ltd:企業の戦略・SWOT・財務情報
    MBNA Ltd - Strategy, SWOT and Corporate Finance Report Summary MBNA Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • SK Kaken Co Ltd (4628):企業の財務・戦略的SWOT分析
    SK Kaken Co Ltd (4628) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • EOG Resources, Inc.:企業の戦略・SWOT・財務情報
    EOG Resources, Inc. - Strategy, SWOT and Corporate Finance Report Summary EOG Resources, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Salem Media Group, Inc.:企業の戦略・SWOT・財務情報
    Salem Media Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Salem Media Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • STR Holdings Inc:企業の戦略的SWOT分析
    STR Holdings Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Meghmani Organics Ltd (MEGH):企業の財務・戦略的SWOT分析
    Summary Meghmani Organics Ltd (Meghmani Organics) is a chemical product manufacturing company. The company develops, produce and markets pigments and pesticides. Its pigments include pigments for plastics, pigments for printing inks and pigments for coatings. Meghmani Organics’ pesticides comprise f …
  • Nippon Steel & Sumikin Bussan Corporation:企業の戦略・SWOT・財務情報
    Nippon Steel & Sumikin Bussan Corporation - Strategy, SWOT and Corporate Finance Report Summary Nippon Steel & Sumikin Bussan Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Aspen Technology Inc (AZPN):企業の財務・戦略的SWOT分析
    Aspen Technology Inc (AZPN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • LafargeHolcim Ltd. :企業の戦略・SWOT・財務情報
    LafargeHolcim Ltd. - Strategy, SWOT and Corporate Finance Report Summary LafargeHolcim Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Warburg Pincus LLC:戦略・SWOT・企業財務分析
    Warburg Pincus LLC - Strategy, SWOT and Corporate Finance Report Summary Warburg Pincus LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Cantabio Pharmaceuticals Inc (CTBO):企業の財務・戦略的SWOT分析
    Summary Cantabio Pharmaceuticals Inc (Cantabio Pharmaceuticals) is a biotechnology company that concentrates on the commercializing of novel therapies for Parkinson’s disease, Alzheimer’s disease and neurodegenerative diseases. The company provide pipeline product candidates such as CB101 and CB102, …
  • PT Central Proteina Prima Tbk (CPRO):企業の財務・戦略的SWOT分析
    PT Central Proteina Prima Tbk (CPRO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Accenture plc:企業のM&A・事業提携・投資動向
    Accenture plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Accenture plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Colabor Group Inc (GCL):企業の財務・戦略的SWOT分析
    Colabor Group Inc (GCL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆